<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>ERYTHROMYCIN-BENZOYL PEROXIDE- erythromycin and benzoyl peroxide 
			 </strong><br>Perrigo New York Inc<br></p></div>
<h1><span class="Bold">Erythromycin-Benzoyl Peroxide Topical Gel</span></h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_fe6159b8-8751-4a29-8e0c-8f68beb36dd7"></a><a name="section-1"></a><p></p>
<p class="First"><span class="Bold">Topical Gel: erythromycin (3%), benzoyl peroxide (5%)</span><br><span class="Bold">For Dermatological Use Only – Not for Ophthalmic Use</span><br><span class="Bold">Reconstitute Before Dispensing</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="ID_026c6720-d94e-445e-9c25-e96050dd5f0d"></a><a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">Erythromycin-Benzoyl Peroxide Topical Gel contains erythromycin [(3R*, 4S*, 5S*, 6R*, 7R*, 9R*, 11R*, 12R*, 13S*, 14R*)-4-[(2,6-Dideoxy-3-<span class="Italics">C</span>-methyl-3-<span class="Italics">O</span>-methyl-α-L-<span class="Italics">ribo</span>-hexopyranosyl)-oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-β-D-<span class="Italics">xylo</span>-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione]. Erythromycin is a macrolide antibiotic produced from a <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> of <span class="Italics">Saccharopolyspora erythraea</span> (formerly <span class="Italics">Streptomyces erythreus</span>). It is a base and readily forms salts with acids.</p>
<p>Chemically, erythromycin is (C<span class="Sub">37</span>H<span class="Sub">67</span>NO<span class="Sub">13</span>). It has the following structural formula:</p>
<div class="Figure">
<a name="id241"></a><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=80397ecd-6069-43dc-b8ae-8703f4b66308&amp;name=image-01.jpg">
</div>
<p>Erythromycin has the molecular weight of 733.94. It is a white crystalline powder and has a solubility of approximately 1 mg/mL in water and is soluble in alcohol at 25°C.</p>
<p>Erythromycin-Benzoyl Peroxide Topical Gel also contains benzoyl peroxide for topical use. Benzoyl peroxide is an antibacterial and keratolytic agent.</p>
<p>Chemically, benzoyl peroxide is (C<span class="Sub">14</span>H<span class="Sub">10</span>O<span class="Sub">4</span>). It has the following structural formula:</p>
<div class="Figure">
<a name="id248"></a><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=80397ecd-6069-43dc-b8ae-8703f4b66308&amp;name=erythromycin-02.jpg">
</div>
<p>Benzoyl peroxide has the molecular weight of 242.23. It is a white granular powder and is sparingly soluble in water and alcohol and soluble in acetone, chloroform and ether.</p>
<p>Each gram of Erythromycin-Benzoyl Peroxide Topical Gel contains, as dispensed, 30 mg (3%) of erythromycin and 50 mg (5%) of benzoyl peroxide in a base of purified water USP, Carbomer Homopolymer Type C, alcohol 20%, sodium hydroxide NF, docusate sodium and fragrance.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="ID_83294831-d46b-47a0-89b1-fe280cf00d02"></a><a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">The exact mechanism by which erythromycin reduces lesions of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span> is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug.</p>
<p>Benzoyl peroxide has a keratolytic and desquamative effect which may also contribute to its efficacy. Benzoyl peroxide has been shown to be absorbed by the skin where it is converted to benzoic acid. </p>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_fc2ac09f-43d6-4351-8e6f-b73546e0e6f0"></a><a name="section-3.1"></a><p></p>
<h2>MICROBIOLOGY</h2>
<p class="First">Erythromycin acts by inhibition of protein synthesis in susceptible organisms by reversibly binding to 50 <span class="Bold">S</span> ribosomal subunits, thereby inhibiting translocation of aminoacyl transfer-RNA and inhibiting polypeptide synthesis. Antagonism has been demonstrated <span class="Italics">in vitro </span>between erythromycin, lincomycin, chloramphenicol and clindamycin.</p>
<p>Benzoyl peroxide is an antibacterial agent which has been shown to be effective against <span class="Italics">Propionibacterium <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acnes</span>, </span>an anaerobe found in sebaceous follicles and comedones. The antibacterial action of benzoyl peroxide is believed to be due to the release of active oxygen.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="ID_99b55d71-d3b0-4d85-b256-7318329e3b1b"></a><a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">Erythromycin-Benzoyl Peroxide Topical Gel is indicated for the topical treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="ID_c7b644cc-f347-433f-96c9-71b92fa6fce0"></a><a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Erythromycin-Benzoyl Peroxide Topical Gel is contraindicated in those individuals who have shown <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to any of its components.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="ID_9ad0dec8-8ef9-4c39-b6d9-6e1a1e4a9943"></a><a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="Bold"><span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">Pseudomembranous colitis</span> has been reported with nearly all antibacterial agents, including erythromycin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span> subsequent to the administration of antibacterial agents.</span></p>
<p>Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by <span class="Italics">Clostridium difficile </span>is one primary cause of "antibiotic-associated <span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>."</p>
<p>After the diagnosis of <span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">pseudomembranous colitis</span> has been established, therapeutic measures should be initiated. Mild cases of <span class="product-label-link" type="condition" conceptid="4265457" conceptname="Pseudomembranous enterocolitis">pseudomembranous colitis</span> usually respond to drug discontinuation alone. In moderate to severe cases, consideration should be given to management with fluids and electrolytes, protein supplementation and treatment with an antibacterial drug clinically effective against <span class="Italics">C. difficile </span><span class="product-label-link" type="condition" conceptid="4272488" conceptname="Colitis">colitis</span>.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="ID_da9df40c-7c0a-4e97-ad1e-a111c149d708"></a><a name="section-7"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="ID_903b8f8d-196e-436e-9fe3-40ec072a3095"></a><a name="section-7.1"></a><p></p>
<h2>General</h2>
<p class="First">For topical use only; not for ophthalmic use. Concomitant topical <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> therapy should be used with caution because a possible cumulative irritancy effect may occur, especially with the use of <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>, desquamating or abrasive agents. If severe irritation develops, discontinue use and institute appropriate therapy.</p>
<p>The use of antibiotic agents may be associated with the overgrowth of nonsusceptible organisms including fungi. If this occurs, discontinue use and take appropriate measures.</p>
<p>Avoid contact with eyes and all mucous membranes.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="ID_ea0c5978-a046-4add-97c7-4c5be3fd79a3"></a><a name="section-7.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Patients using Erythromycin-Benzoyl Peroxide Topical Gel should receive the following information and instructions:</p>
<dl>
<dt>•</dt>
<dd>This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes, nose, mouth, and all mucous membranes.</dd>
<dt>•</dt>
<dd>This medication should not be used for any disorder other than that for which it was prescribed.</dd>
<dt>•</dt>
<dd>Patients should not use any other topical <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> preparation unless otherwise directed by physician.</dd>
<dt>•</dt>
<dd>Patients should report to their physician any signs of local adverse reactions.</dd>
<dt>•</dt>
<dd>Erythromycin-Benzoyl Peroxide Topical Gel may bleach hair or colored fabric.</dd>
<dt>•</dt>
<dd>Keep product refrigerated and discard after 3 months.</dd>
</dl>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="ID_e24f0da2-65d9-4e8f-8d21-e396462291b9"></a><a name="section-7.3"></a><p></p>
<h2>CARCINOGENESIS, MUTAGENESIS AND IMPAIRMENT OF FERTILITY</h2>
<p class="First">Data from a study using mice known to be highly susceptible to cancer suggests that benzoyl peroxide acts as a tumor promoter. The clinical significance of this is unknown.</p>
<p>No animal studies have been performed to evaluate the carcinogenic and mutagenic potential or effects on fertility of topical erythromycin. However, long-term (2-year) oral studies in rats with erythromycin ethylsuccinate and erythromycin base did not provide evidence of tumorigenicity. There was no apparent effect on male or female fertility in rats fed erythromycin (base) at levels up to 0.25% of diet.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="ID_a77d5783-81e6-49ce-8f44-4cc5c03a384c"></a><a name="section-7.4"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="ID_da96afb0-d763-4cfc-9178-7501a3aea6b1"></a><a name="section-7.4.1"></a><p></p>
<h3><span class="Bold">Teratogenic Effects</span></h3>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_66bd6e01-d3c9-4db1-8f22-7598247d4798"></a><a name="section-7.4.1.1"></a><p></p>
<h4><span class="Bold">Pregnancy CATEGORY C</span></h4>
<p class="First">Animal reproduction studies have not been conducted with Erythromycin-Benzoyl Peroxide Topical Gel or benzoyl peroxide.</p>
<p>There was no evidence of <span class="product-label-link" type="condition" conceptid="4240324" conceptname="Teratogenesis">teratogenicity</span> or any other adverse effect on reproduction in female rats fed erythromycin base (up to 0.25% diet) prior to and during mating, during gestation and through weaning of two successive litters. </p>
<p>There are no well-controlled trials in pregnant women with Erythromycin-Benzoyl Peroxide Topical Gel. It also is not known whether Erythromycin-Benzoyl Peroxide Topical Gel can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity. Erythromycin-Benzoyl Peroxide Topical Gel should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="ID_e5115fba-7df3-4513-a2ce-71d279de4074"></a><a name="section-7.5"></a><p></p>
<h2>Nursing Women</h2>
<p class="First">It is not known whether Erythromycin-Benzoyl Peroxide Topical Gel is excreted in human milk after topical application. However, erythromycin is excreted in human milk following oral and parenteral erythromycin administration. Therefore, caution should be exercised when erythromycin is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="ID_29ccd7d0-ab9b-437b-ae70-a3c3aaa10db1"></a><a name="section-7.6"></a><p></p>
<h2>Pediatric Use</h2>
<p class="First">Safety and effectiveness of this product in pediatric patients below the age of 12 have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="ID_7a56ead4-2abe-4fa6-b125-48a537d0636b"></a><a name="section-8"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">In controlled clinical trials, the incidence of adverse reactions associated with the use of Erythromycin-Benzoyl Peroxide Topical Gel was approximately 3%. These were dryness and urticarial reaction.</p>
<p>The following additional local adverse reactions have been reported occasionally: irritation of the skin including <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, <span class="product-label-link" type="condition" conceptid="4235891" conceptname="Burning sensation">burning sensation</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span> of the face, eyes and nose, and irritation of the eyes. <span class="product-label-link" type="condition" conceptid="135030" conceptname="Discoloration of skin">Skin discoloration</span>, oiliness and <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span> of the skin have also been reported.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="ID_15ed9eb4-7d09-45e8-a6a3-643e5fd259ce"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Erythromycin-Benzoyl Peroxide Topical Gel should be applied twice daily, morning and evening, or as directed by a physician, to affected areas after the skin is thoroughly washed, rinsed with warm water and gently patted dry.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="ID_fa79e529-d09e-42e0-97c3-34ef4ac18279"></a><a name="section-10"></a><p></p>
<p class="First"><span class="Bold">How Supplied and Compounding Directions:</span></p>
<table width="100%">
<col width="20%">
<col width="15%">
<col width="20%">
<col width="23%">
<col width="22%">
<thead><tr class="First Last">
<th class="Botrule Toprule" align="left" valign="top">
<span class="Bold">Size</span><br><span class="Bold">(Net Weight)</span>
</th>
<th class="Botrule Toprule" align="left" valign="bottom"><span class="Bold">NDC 45802-083-</span></th>
<th class="Botrule Toprule" align="left" valign="top"><span class="Bold">Benzoyl Peroxide Gel</span></th>
<th class="Botrule Toprule" align="left" valign="top"><span class="Bold">Active Erythromycin Powder (In Plastic Vial)</span></th>
<th class="Botrule Toprule" align="left" valign="top"><span class="Bold">70% Ethyl Alcohol To Be Added</span></th>
</tr></thead>
<tbody>
<tr class="First">
<td class="Botrule Rrule Toprule"><p class="First">23.3 grams<br>(as dispensed)</p></td>
<td class="Botrule Rrule Toprule"><p class="First">02</p></td>
<td class="Rrule Toprule"><p class="First">20 grams</p></td>
<td class="Botrule Rrule Toprule"><p class="First">0.8 grams</p></td>
<td class="Botrule Toprule"><p class="First">3 mL</p></td>
</tr>
<tr class="Last">
<td class="Botrule Rrule"><p class="First">46.6 grams<br> (as dispensed)</p></td>
<td class="Botrule Rrule"><p class="First">86</p></td>
<td class="Botrule Rrule"><p class="First">40 grams</p></td>
<td class="Botrule Rrule"><p class="First">1.6 grams</p></td>
<td class="Botrule"><p class="First">6 mL</p></td>
</tr>
</tbody>
</table>
<p><span class="Bold">Prior to dispensing, tap vial until all powder flows freely. Add indicated amount of room temperature 70% ethyl alcohol  to vial (to the mark) and immediately shake to completely dissolve erythromycin</span>. Add this solution to gel and stir until homogeneous in appearance (1 to 1½ minutes). Erythromycin-Benzoyl Peroxide Topical Gel should then be stored under refrigeration. Do not freeze. Place a 3-month expiration date on the label. </p>
<div class="Section" data-sectionCode="44425-7">
<a name="ID_db81b7e7-4c72-4146-b4d1-31430914e7d8"></a><a name="section-10.1"></a><p></p>
<p class="First"><span class="Bold">NOTE: <span class="Italics">Prior to reconstitution,</span> store at room temperature between 15° and 30°C (59° – 86°F).</span></p>
<p><span class="Bold"><span class="Italics">After reconstitution,</span> store under refrigeration between 2° and 8°C (36° – 46°F).</span></p>
<p><span class="Bold">Do not freeze. Keep tightly closed. Keep out of the reach of children.</span></p>
<p><span class="Bold">Rx Only</span></p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_3066b58b-a7dc-4cef-8e18-2a7ce79d1e65"></a><a name="section-11"></a><p></p>
<p class="First">Manufactured by:<br>Valeant Pharmaceuticals International Inc.<br>Laval, Quebec, Canada H7L 4A8</p>
<p>Distributed by:<br>Perrigo<span class="Sup">®</span><br>Allegan, MI 49010</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="ID_8cb52c24-0dce-4d77-8184-fc76199ee6e9"></a><a name="section-12"></a><p></p>
<p class="First">Erythromycin-Benzoyl Peroxide Topical Gel</p>
<table width="100%">
<col width="100%">
<tbody class="Headless">
<tr class="First"><td class="Botrule Lrule Rrule Toprule"><p class="First"><span class="Bold">PLEASE READ COMPLETE COMPOUNDING DIRECTIONS</span></p></td></tr>
<tr class="Last"><td class="Botrule Lrule Rrule"><p class="First"><span class="Bold">NOTE:</span> TAP VIAL UNTIL ALL POWDER FLOWS FREELY. ADD ROOM TEMPERATURE 70% ETHYL ALCOHOL TO VIAL (TO THE MARK) AND <span class="Bold">IMMEDIATELY</span> SHAKE/DISSOLVE <span class="Bold">COMPLETELY.</span></p></td></tr>
</tbody>
</table>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_9ab12755-4662-40f3-92b4-47fd2eb8e748"></a><a name="section-13"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 46.6g Jar Carton</h1>
<p class="First"><span class="Bold">Rx Only</span></p>
<p>NDC 45802-<span class="Bold">083</span>-86</p>
<p><span class="Bold">Erythromycin-Benzoyl </span></p>
<p><span class="Bold">Peroxide Topical Gel</span></p>
<p><span class="Bold">For Topical Use Only</span></p>
<p><span class="Bold">One 46.6 g Jar (as dispensed)</span></p>
<p><span class="Bold">PERRIGO</span><span class="Sup">®</span></p>
<div class="Figure">
<a name="id536"></a><img alt="Erythromycin-Benzoyl Peroxide Topical Gel 1st Image  46.6 g Jar" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=80397ecd-6069-43dc-b8ae-8703f4b66308&amp;name=erythromycin-03.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="ID_4c9564a9-6c5e-47f0-ac25-8dff19b583de"></a><a name="section-14"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 46.6g Jar Carton</h1>
<div class="Figure">
<a name="id-247429711"></a><img alt="Erythromycin-Benzoyl Peroxide Topical Gel 2nd Image 46.6 g Jar" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=80397ecd-6069-43dc-b8ae-8703f4b66308&amp;name=Principal%20Display%20Panel%20-%20Erythromycin%202.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>ERYTHROMYCIN-BENZOYL PEROXIDE 		
					</strong><br><span class="contentTableReg">erythromycin and benzoyl peroxide kit</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:45802-083</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:45802-083-86</td>
<td class="formItem">1  in 1 BOX</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Quantity of Parts</td></tr>
<tr>
<th scope="col" width="5" class="formTitle">Part #</th>
<th scope="col" class="formTitle">Package Quantity</th>
<th scope="col" class="formTitle">Total Product Quantity</th>
</tr>
<tr class="formTableRowAlt">
<td width="5" class="formItem"><strong>Part 1</strong></td>
<td class="formItem">1 VIAL, PLASTIC </td>
<td class="formItem">1.6 g</td>
</tr>
<tr class="formTableRow">
<td width="5" class="formItem"><strong>Part 2</strong></td>
<td class="formItem">1 JAR </td>
<td class="formItem">40 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 1 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>ERYTHROMYCIN 		
					</strong><br><span class="contentTableReg">erythromycin powder, for solution</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ERYTHROMYCIN</strong> (ERYTHROMYCIN) </td>
<td class="formItem">ERYTHROMYCIN</td>
<td class="formItem">30 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">1.6 g in 1 VIAL, PLASTIC</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA authorized generic</td>
<td class="formItem">NDA050557</td>
<td class="formItem">10/26/1984</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellspacing="0" cellpadding="5">
<tr><td class="contentTableTitle">Part 2 of 2</td></tr>
<tr><td class="contentTableTitle">
<strong>BENZOYL PEROXIDE 		
					</strong><br><span class="contentTableReg">benzoyl peroxide gel</span>
</td></tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt"></tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>BENZOYL PEROXIDE</strong> (BENZOYL PEROXIDE) </td>
<td class="formItem">BENZOYL PEROXIDE</td>
<td class="formItem">50 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED)</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ALCOHOL</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>DOCUSATE SODIUM</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">40 g in 1 JAR</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA authorized generic</td>
<td class="formItem">NDA050557</td>
<td class="formItem">10/26/1984</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA authorized generic</td>
<td class="formItem">NDA050557</td>
<td class="formItem">10/26/1984</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Perrigo New York Inc
							(078846912)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Valeant Pharmaceuticals International, Inc</td>
<td class="formItem"></td>
<td class="formItem">245141858</td>
<td class="formItem">MANUFACTURE(45802-083)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 12/2014<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>4affcac1-7e58-4248-8466-d4b0395fa663</div>
<div>Set id: 80397ecd-6069-43dc-b8ae-8703f4b66308</div>
<div>Version: 6</div>
<div>Effective Time: 20141208</div>
</div>
</div> <div class="DistributorName">Perrigo New York Inc</div></p>
</body></html>
